• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New York State Department of Health Announces Emergence of Recently Identified, Highly Contagious Omicron Subvariants in New York and Urges Continued

Mary Wilson

Well-known member
Department's Wadsworth Center Identifies Two Sub-lineages of BA.2—BA.2.12 and BA.2.12.1—Potentially Contributing to Increased Transmission Reported in Central New York and Surrounding Regions

Department Reminds All New Yorkers to Get Fully Vaccinated/Boosted, Consider Wearing a Mask in Public Indoor Spaces, Test Following Exposure/Symptoms, Seek Treatment/Stay Home if COVID-Positive and Consult with Healthcare Provider Regarding Treatments

ALBANY, N.Y. (April 13, 2022) The New York State Department of Health today announced the emergence of two Omicron subvariants in New York State, BA.2.12 and BA.2.12.1. Both variants are sub-lineages of BA.2, which now accounts for 80.6% of COVID-19 infections in New York. The subvariants have been estimated to have a 23% – 27% growth advantage above the original BA.2 variant. Over the past few weeks, the Department has been investigating higher than average infection rates in Central New York. Based on newly available data in the public database, GISAID, as well as additional data submitted directly to the Wadsworth Center from sequencing laboratories in New York, State health officials have determined that these highly contagious new variants are likely contributing to the rising cases. For the month of March, BA.2.12 and BA.2.12.1 rose to collectively comprise more than 70% prevalence in Central New York and more than 20% prevalence in the neighboring Finger Lakes region. Data for April indicate that levels in Central New York are now above 90%. The Department's findings are the first reported instances of significant community spread due to the new subvariants in the United States. At this time, there is no evidence of increased disease severity by these subvariants, though the Department is closely monitoring for any changes.

"We are alerting the public to two Omicron subvariants, newly emerged and rapidly spreading in upstate New York, so New Yorkers can act swiftly," said State Health Commissioner Dr. Mary T. Bassett. ...

https://www.health.ny.gov/press/releases/2022/2022-04-13_covid-19.htm
 
Back
Top